AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 22 min read$AXON

Williams Jeri sold $102K of AXON

Williams Jeri sold 223 shares of AXON ENTERPRISE, INC. (AXON) at $455.45 ($0.10M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Williams Jeri
Published Jun 2, 2026, 9:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider activity, but the pre-arranged nature generally limits interpretability for near-term trading decisions.

02

Market read

Useful for tracking insider behavior, but not a standalone fundamental catalyst for AXON.

03

What to watch

The filing does not reveal intent beyond the plan; consider the director’s broader trading history and whether other insiders filed around the same time.

Relevance 4/10Novelty 2/10Timing: Filed after-hours/late day (2026-06-02) for a sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction disclosure for AXON, reporting an open-market sale by a director under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Director Williams Jeri filed an open-market sale of 223 AXON shares under a pre-arranged 10b5-1 plan on 2026-06-01.

Expected impact

Low likelihood of a sustained price move from this filing alone; any impact is likely limited to short-term sentiment.

Evidence & confidence

The transaction is an open-market sale and explicitly tied to a pre-arranged 10b5-1 plan, which reduces informational content versus unscheduled sales.

Market effects

Sector

Minimal—single-company insider transaction without accompanying operational or financial catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with 10b5-1, repeated or sizable insider sales can coincide with periods of valuation risk or personal liquidity needs—monitor for clustering of similar filings.

Key entities

  • public_company
    AXON ENTERPRISE, INC.

    Issuer of the reported insider transaction (director sale) disclosed via SEC Form 4.

  • insider
    Williams Jeri

    Director who sold 223 shares of AXON on 2026-06-01 under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 7
$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

aol.com4 min
AUG 6
$AXONMedAI 8/10

Axon Just Delivered a Huge Beat-and-Raise. So Why Is the Stock Down?

Axon Enterprise (AXON) reported Q2 revenue of $904 million, up 35% year over year, versus $876.5 million expected, with TASER revenue up 21% to $261.3 million. Adjusted EBITDA rose 40% to $242 million and adjusted EPS was $1.88. The company raised full-year revenue guidance to 32%-34% growth and maintained 25.5% adjusted EBITDA margin, but the stock fell after hours and during the session.

fool.com6 min
AUG 5
$AXONMed

Axon Enterprise Stock Slips After Q2 Earnings - Axon Enterprise (NASDAQ:AXON)

Axon Enterprise reported Q2 revenue of $904.39 million, above the $876.46 million estimate, and adjusted EPS of $1.88, above $1.85, according to Benzinga Pro. Software and Services revenue rose to $398 million and Connected Devices to $507 million. Annual recurring revenue increased to $1.6 billion. The company raised 2026 guidance to $3.67-$3.73 billion. Shares fell 6.32% after hours to $570.95.

benzinga.com2 min
AUG 5
$AXONMed

Axon posts lower quarterly gross margin on higher mix of services, new product scaling

Axon Enterprise reported lower Q2 gross margin, citing a higher mix of professional services and spending to scale new product offerings, according to Reuters. Adjusted gross margin in its software and services segment fell 3.8 points to 75.1%. Revenue rose to $904 million, above $877 million estimates, and adjusted EPS was $1.88 vs $1.85 expected. Shares fell over 6% after hours.

investing.com3 min
AUG 5
$AXONHighAI 9/10

AXON ENTERPRISE, INC. (AXON): Results of Operations and Financial Condition

AXON ENTERPRISE, INC. (AXON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 axon-20260805xex991.htm EX-99.1 Document Exhibit 99.1 CONTACT: Investor Relations Axon Enterprise, Inc. IR@axon.com Axon reports Q2 2026 revenue of $904 million, up 35% year over year • Annual recurring revenue grows 39% to $1.6 billion; net revenue retention reaches 12

SEC EDGAR 8-K6 min